Cerebrospinal fluid concentrations of nitric oxide metabolites in spinal cord injury

Spine

Volumn 34, Issue 18, 2009, Pages

  Kimura, Shinji ^a   Hosaka, Noboru ^b   Yuge, Itaru ^c   Yamazaki, Akiyoshi ^d   Suda, Kohta ^e   Taneichi, Hiroshi ^f   Denda, Hiroshi ^g   Endo, Naoto ^d,g  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b Japan Organization of Occupational Health and Safety   (Japan)

^c SPINAL INJURIES CENTER   (Japan)

^d Niigata Central Hospital   (Japan)

^e Japan Labor Health and Welfare Organization   (Japan)

^f DOKKYO MEDICAL UNIVERSITY   (Japan)

^g NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Cerebrospinal fluid; Neurologic recovery; Neurologic severity; Nitric oxide metabolites; Spinal cord injury

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; LAMINOPLASTY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; SPINAL CORD INJURY; THORAX INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NITRIC OXIDE; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SPINAL CORD INJURIES; TIME FACTORS; YOUNG ADULT;

EID: 69749092478     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181abda1d     Document Type: Article

References (48)

1. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
2. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997;3:73-76 (Pubitemid 27019144)
3. Wada S, Yone K, Ishidou Y, et al. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J Neurosurg 1999;91(suppl 1):98-104.
4. Ha Y, Kim YS, Cho JM, et al. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J Neurosurg Spine 2005;2:55-61.
5. Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94. (Pubitemid 19004828)
6. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142
7. Kimura S, Uchiyama S, Takahashi HE, et al. cAMP-dependent long-term potentiation of nitric oxide release from cerebellar parallel fibers in rats. J Neurosci 1998;18:8551-8558 (Pubitemid 28491722)
8. Kimura S, Yajiri Y, Uchiyama S, et al. Nitric oxide release from substantia gelatinosa of the rat spinal cord in vitro. Neurosci Lett 1999;275:199-202. (Pubitemid 29507541)
9. Hamada Y, Ikata T, Katoh S, et al. Roles of nitric oxide in compression injury of rat spinal cord. Free Radic Biol Med 1996;13:1-9. (Pubitemid 26014315)
10. Nakahara S, Yone K, Setoguchi T, et al. Change in nitric oxide synthase in spinal cord after traumatic injury in rats. J Neurotrauma 2002;11:1467-1474
11. Xu J, Kim GM, Chen S, et al. iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 2001;18:523-532 (Pubitemid 32472842)
12. Wang X, Kimura S, Kakita A, et al. Nitric oxide in cerebrospinal fluid and local inducible nitric oxide synthase after cauda equina compression in rats. Neuroreport 2006;17:1473-1478 (Pubitemid 44359455)
13. Dawson VL, Dawson TM, Bartley DA, et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-2661
14. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 2002;115:839-849 (Pubitemid 35336026)
15. Estevetz AG, Spear N, Manuel SM, et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998;18:923-931 (Pubitemid 28112915)
16. Isaksson J, Farooque M, Olsson Y. Improved functional outcome after spinal cord injury in iNOS-deficient mice. Spinal Cord 2005;43:167-170 (Pubitemid 40432661)
17. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
18. Selden NR, Quint DJ, Patel N, et al. Emergency magnetic resonance imaging of cervical spinal cord injuries: clinical correlation and prognosis. Neurosurgery 1999;44:785-793 (Pubitemid 29153572)
19. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia: part 1. Paraplegia 1969;7:179-192
20. Marino RJ, Ditunno JF, Donovan WH, et al. Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems. Arch Phys Med Rehabil 1999;80:1391-1396 (Pubitemid 29526635)
21. Hosaka N, Kimura S, Yamazaki A, et al. Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury. Eur Spine J 2008;17:281-286 (Pubitemid 351197874)
22. Kakulas BA, Taylor JR. Pathology of injuries of the vertebral column and spinal cord. In: Frankel HL, ed. Handbook of Clinical Neurology. Vol 17. Amsterdam, The Netherlands: Elsevier Science Publishers; 1992:39-41.
23. Moshage H, Kok B, Huizenga JR, et al. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41:892-896
24. Griess JP. On a new series of bodies in which nitrogen is substituted for hydrogen. Phil Trans R Soc (Lond) 1964;154:667-731.
25. Kimura S, Watanabe K, Yajiri Y, et al. Cerebrospinal fluid nitric oxide metabolites in painful diseases. Neuroreport 1999;10:275-279 (Pubitemid 29104799)
26. Kimura S, Watanabe K, Yajiri Y, et al. Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain relief in degenerative lumbar diseases. Pain 2001;92:363-371 (Pubitemid 32480166)
27. Kimura S, Ito T, Watanabe K, et al. Prediction of postoperative pain relief in degenerative lumbar diseases using CSF nitric oxide metabolites: multiple center study. Spine J 2005;5:10S-11S.
28. Maynard FM, Bracken MB Jr, Creasey G, et al. International standards for neurological and functional classification of spinal cord injury. Spinal Cord 1997;35:266-274 (Pubitemid 27235039)
29. EL Masry WS, Katoh S, Khan A. Reflections on the neurological significance of bony canal encroachment following traumatic injury of the spine in patients with Frankel C, D, and E presentation. J Neurotrauma 1993;10 (suppl 1):S70.
30. El Masry WS, Tsubo M, Katoh S, et al. Validation of the American Spinal Injury Association (ASIA) motor score and the National Acute Spinal Cord Injury Study (NASCIS) motor score. Spine 1996;21:614-619 (Pubitemid 26077802)
31. Katoh S, El Masry WS, Jaffray D, et al. Neurological outcome in conservatively treated patients with incomplete closed traumatic cervical spinal cord injuries. Spine 1996;21:2345-2351 (Pubitemid 26362116)
32. Wang X, Kimura S, Yazawa T, et al. Cerebrospinal fluid sampling by lumbar puncture in rats -repeated measurements of nitric oxide metabolites. J Neurosci Meth 2005;145:89-95. (Pubitemid 40732435)
33. Clark RS, Kochanek PM, Obrist WD, et al. Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans. Crit Care Med 1996;24:1243-1251
34. Danilov AI, Andersson M, Bavand N, et al. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 2003;136:112-118 (Pubitemid 36300799)
35. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature 1993;364:626-632 (Pubitemid 23274719)
36. Emery E, Aldana P, Bunge MB, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998;89:911-920 (Pubitemid 28544043)
37. Denda H, Kimura S, Yamazaki A, et al. Clinical significant of CSF nitric oxide concentrations in cervical degenerative disease. The proceeding of AAOS 2008;629.
38. Nishisho T, Tonai T, Tamura Y, et al. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. Neurosurg 1996;39:950-957 (Pubitemid 26360852)
39. Fehlings MG, Sekhon LH, Tator CH. The role and timing of decompression in acute spinal cord injury. Spine 2001;26:S101-10.
40. Fehlings MG, Perrin RG. The timing of surgical intervention in the treatment of spinal cord injury: a systemic review of recent clinical evidence. Spine 2006;31:S28-35.
41. Bracken MB, Shepard MJ, Collins WF, et al. A randomized controlled trial of methylprednisolone or naloxone used the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-1411
42. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 1993;79:500-507
43. Tsutsumi S, Ueta T, Shiba K, et al. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine 2006;31:2992-2996 (Pubitemid 46005887)
44. Yu Y, Matsuyama Y, Nakashima S, et al. Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Neuroreport 2004;15:2103-2107 (Pubitemid 39281755)
45. Zeidman SM, Ling GS, Ducker TB, et al. Clinical applications of pharmacologic therapies for spinal cord injury. J Spinal Disord 1996;9:367-380 (Pubitemid 26423730)
46. Short DJ, EL Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: a systemic review from a clinical perspective. Spinal Cord 2000;38:273-286
47. Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the Second National Spinal Cord Injury Study (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000;13:185-199
48. Matsumoto T, Tamaki T, Kawakami M, et al. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute-cervical spinal cord injury. Spine 2001;26:426-430 (Pubitemid 32184858)